Ajaswrata Dutta
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ajaswrata Dutta has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
Akshu Dahiya
Radiomitigation Research Department, Defence Research and Development Organization (DRDO), Institute of Nuclear Medicine and Allied Sciences (INMAS), Delhi, India
4 shared publications- Akshu Dahiya
Radiomitigation Research Department, Institute of Nuclear Medicine and Allied Sciences (INMAS), Defence Research and Development Organization (DRDO), Brig. S.K Mazumdar Marg, Delhi, India
3 shared publications - Banashree Mitra
University of Mississippi
3 shared publications N. Durgaprasad
3 shared publications- Paban Kumar Agrawala
Radiation Genetics and Epigenetics Department, Institute of Nuclear Medicine and Allied Sciences
3 shared publications - Shubhadeep Biswas
Max Planck Institute of Quantum Optics Garching Germany
3 shared publications
Latest Publications
- Open Access
- 8 January 2026
- Published by The ScienceIn Publishing in Biomedical and Therapeutics Letters
- Vol. 13 (1)
Raloxifene drug enhances stem cell proliferation by inducing the expression of STAT3
Cell proliferation is a complex process that requires the coordination of multiple signaling cascades. In this study, we aimed to identify cell Raloxifene to induce cell proliferation and tissue repair. Raloxifene is an estrogen receptor modulator that helps with osteoporosis post-menopause. We evaluated their role in cell proliferation and molecular mechanism of action via molecular docking, Molecular dynamic (MD) simulation, MM-PBSA analysis, and PCA analysis. Furthermore, the in vitro cell proliferation was evaluated using MTT, BrdU, Ki-67 immunochemistry, cell cycle analysis and in vivo for a whole-body irradiated model for survival by inducing cell proliferation. Our findings suggested that the identified drug, Raloxifene, interacts with STAT3 with -8.1 Kcal/mol binding energy and 0.126±0.177 nm RMSD. In vitro results showed that Raloxifene significantly (pvalue2.5) induced STAT3, followed by Cyclin B, thus enhancing cell proliferation. We also observed a 100 % survival rate in the Raloxifene-treated group compared to the irradiated group. This work may be helpful accelerating proliferation of soft tissue repair in case of combat injuries, radiation injuries, blood pharming, and hematopoietic reconstitution.
- 8 January 2026
- Published by The ScienceIn Publishing in Biomedical and Therapeutics Letters
- Vol. 13 (1)
Open AccessRaloxifene drug enhances stem cell proliferation by inducing the expression of STAT3
Cell proliferation is a complex process that requires the coordination of multiple signaling cascades. In this study, we aimed to identify cell Raloxifene to induce cell proliferation and tissue repair. Raloxifene is an estrogen receptor modulator that helps with osteoporosis post-menopause. We evaluated their role in cell proliferation and molecular mechanism of action via molecular docking, Molecular dynamic (MD) simulation, MM-PBSA analysis, and PCA analysis. Furthermore, the in vitro cell proliferation was evaluated using MTT, BrdU, Ki-67 immunochemistry, cell cycle analysis and in vivo for a whole-body irradiated model for survival by inducing cell proliferation. Our findings suggested that the identified drug, Raloxifene, interacts with STAT3 with -8.1 Kcal/mol binding energy and 0.126±0.177 nm RMSD. In vitro results showed that Raloxifene significantly (pvalue2.5) induced STAT3, followed by Cyclin B, thus enhancing cell proliferation. We also observed a 100 % survival rate in the Raloxifene-treated group compared to the irradiated group. This work may be helpful accelerating proliferation of soft tissue repair in case of combat injuries, radiation injuries, blood pharming, and hematopoietic reconstitution.
- 25 November 2024
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 101 (1) , 15-27
Trichostatin A mitigates acute and late effects of radiation in intestine by regulation of DNA damage repair and Wnt/TGFβ/Smad signaling
Radiation exposure, whether accidental or intentional, posses significant health complications and survival concerns in humans. The gastrointestine (GI), is the second most radio-sensitive organ, e...
- 25 November 2024
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 101 (1) , 15-27
Trichostatin A mitigates acute and late effects of radiation in intestine by regulation of DNA damage repair and Wnt/TGFβ/Smad signaling
Radiation exposure, whether accidental or intentional, posses significant health complications and survival concerns in humans. The gastrointestine (GI), is the second most radio-sensitive organ, e...
- 8 November 2024
- Published by Taylor & Francis in Biomarkers
- Vol. 29 (8) , 505-517
A data mining approach to identify key radioresponsive genes in mouse model of radiation-induced intestinal injury
- 8 November 2024
- Published by Taylor & Francis in Biomarkers
- Vol. 29 (8) , 505-517
A data mining approach to identify key radioresponsive genes in mouse model of radiation-induced intestinal injury
- Open Access
- 1 November 2024
- Published by The ScienceIn Publishing in Chemical Biology Letters
- Vol. 12 (1) , 1255
Uncovering the potential of Fatty Acid Binding Proteins for predicting radiation-induced gastrointestinal injury
Gastrointestine (GI) depression is a severe complication identified in individuals after intentional or unintentional radiation exposure. Early detection of radiation-induced GI injury (RIGI) is important for medical management with supportive care, which can largely be achieved using organ specific biomarkers. Fatty Acid Binding Proteins (FABPs) are 14-15 kDa cytosolic proteins which are quickly released into circulation in the event of tissue injuries. The present investigation aims to unravel the potential of FABPs as candidate targets to predict RIGI. Utilizing data mining approach, FABP genes differentially expressed in 06 microarray datasets retrieved from Gene Expression Omnibus (GEO) database across distinct species were identified. The abundance of 10 genes encoding FABPs were checked in intestinal tissue of male and female C57Bl/6 mice by qRT-PCR analysis. FABP1 and FABP2 were identified as the abundant genes expressed in small intestine of both the sexes. In order to explore FABP1 and FABP2 as possible targets for radioprotection, we selected approved hydrophilic and lipophilic statins to perform molecular docking studies. The findings highlighted that FABP1 and FABP2, expressed in intestine, can act as potential biomarkers for RIGI as well as their drug targets can be explored as promising radiation countermeasure agents.
- 1 November 2024
- Published by The ScienceIn Publishing in Chemical Biology Letters
- Vol. 12 (1) , 1255
Open AccessUncovering the potential of Fatty Acid Binding Proteins for predicting radiation-induced gastrointestinal injury
Gastrointestine (GI) depression is a severe complication identified in individuals after intentional or unintentional radiation exposure. Early detection of radiation-induced GI injury (RIGI) is important for medical management with supportive care, which can largely be achieved using organ specific biomarkers. Fatty Acid Binding Proteins (FABPs) are 14-15 kDa cytosolic proteins which are quickly released into circulation in the event of tissue injuries. The present investigation aims to unravel the potential of FABPs as candidate targets to predict RIGI. Utilizing data mining approach, FABP genes differentially expressed in 06 microarray datasets retrieved from Gene Expression Omnibus (GEO) database across distinct species were identified. The abundance of 10 genes encoding FABPs were checked in intestinal tissue of male and female C57Bl/6 mice by qRT-PCR analysis. FABP1 and FABP2 were identified as the abundant genes expressed in small intestine of both the sexes. In order to explore FABP1 and FABP2 as possible targets for radioprotection, we selected approved hydrophilic and lipophilic statins to perform molecular docking studies. The findings highlighted that FABP1 and FABP2, expressed in intestine, can act as potential biomarkers for RIGI as well as their drug targets can be explored as promising radiation countermeasure agents.
- 29 August 2023
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 99 (12) , 1865-1878
Mitigative and anti-inflammatory effects of Trichostatin A against radiation-induced gastrointestinal toxicity and gut microbiota alteration in mice
Radiation-induced gastrointestinal injury (RIGI) is a serious side effect of abdominal and pelvic radiotherapy, which often limits the treatment of gastrointestinal and gynaecological cancers. RIGI is also observed during accidental radiological or nuclear scenarios with no approved agents available till date to prevent or mitigate RIGI in humans. Trichostatin A (TSA), an epigenetic modulator, has been currently in clinical trials for cancer treatment and is also well known for its antibiotic and antifungal properties. In this study, partial body (abdominal) irradiation mice model has been used to investigate the mitigative effect of TSA against gastrointestinal toxicity caused by gamma radiation. Mice were checked for alterations in mean body weight, diarrhea incidence, disease activity index and survival against radiation. Structural abnormalities in intestine and changes in microbiota composition were studied by histopathology and 16S rRNA sequencing of fecal samples respectively. Immunoblotting and biochemical assays were performed to check protein nitrosylation, expression of inflammatory mediators, infiltration of inflammatory cells and changes in pro-inflammatory cytokines. TSA administration to C57Bl/6 mice improved radiation induced mean body weight loss, maintained better health score, reduced disease activity index and promoted survival. The 16S rRNA sequencing of fecal DNA demonstrated that TSA influenced the fecal microbiota dynamics with significant alterations in the Firmicutes/Bacteriodetes ratio. TSA effectively mitigated intestinal injury, down-regulated NF-κB, Cox-2, iNOS, inhibited PGE2 and protein nitrosylation levels in irradiated intestine. The upregulation of NLRP3-inflammasome complex and infiltrations of inflammatory cells in the inflamed intestine were also prevented by TSA. Subsequently, the myeloperoxidase activity in intestine alongwith serum IL-18 levels was found reduced. These findings provide evidence that TSA inhibits inflammatory mediators, alleviates gut dysbiosis, and promotes structural restoration of the irradiated intestine. TSA, therefore, can be considered as a potential agent for mitigation of RIGI in humans.
- 29 August 2023
- Published by Taylor & Francis in International Journal of Radiation Biology
- Vol. 99 (12) , 1865-1878
Mitigative and anti-inflammatory effects of Trichostatin A against radiation-induced gastrointestinal toxicity and gut microbiota alteration in mice
Radiation-induced gastrointestinal injury (RIGI) is a serious side effect of abdominal and pelvic radiotherapy, which often limits the treatment of gastrointestinal and gynaecological cancers. RIGI is also observed during accidental radiological or nuclear scenarios with no approved agents available till date to prevent or mitigate RIGI in humans. Trichostatin A (TSA), an epigenetic modulator, has been currently in clinical trials for cancer treatment and is also well known for its antibiotic and antifungal properties. In this study, partial body (abdominal) irradiation mice model has been used to investigate the mitigative effect of TSA against gastrointestinal toxicity caused by gamma radiation. Mice were checked for alterations in mean body weight, diarrhea incidence, disease activity index and survival against radiation. Structural abnormalities in intestine and changes in microbiota composition were studied by histopathology and 16S rRNA sequencing of fecal samples respectively. Immunoblotting and biochemical assays were performed to check protein nitrosylation, expression of inflammatory mediators, infiltration of inflammatory cells and changes in pro-inflammatory cytokines. TSA administration to C57Bl/6 mice improved radiation induced mean body weight loss, maintained better health score, reduced disease activity index and promoted survival. The 16S rRNA sequencing of fecal DNA demonstrated that TSA influenced the fecal microbiota dynamics with significant alterations in the Firmicutes/Bacteriodetes ratio. TSA effectively mitigated intestinal injury, down-regulated NF-κB, Cox-2, iNOS, inhibited PGE2 and protein nitrosylation levels in irradiated intestine. The upregulation of NLRP3-inflammasome complex and infiltrations of inflammatory cells in the inflamed intestine were also prevented by TSA. Subsequently, the myeloperoxidase activity in intestine alongwith serum IL-18 levels was found reduced. These findings provide evidence that TSA inhibits inflammatory mediators, alleviates gut dysbiosis, and promotes structural restoration of the irradiated intestine. TSA, therefore, can be considered as a potential agent for mitigation of RIGI in humans.
- 4 February 2023
- Published by Elsevier in Phytomedicine
- Vol. 112, 154692
Quercetin 3-O rutinoside prevents gastrointestinal injury through regulation of apoptosis in 7.5 Gy total body irradiated mice
- 4 February 2023
- Published by Elsevier in Phytomedicine
- Vol. 112, 154692
Quercetin 3-O rutinoside prevents gastrointestinal injury through regulation of apoptosis in 7.5 Gy total body irradiated mice
- Open Access
- 27 November 2022
- Published by Elsevier in Phytomedicine Plus
- Vol. 3 (1)
Quercetin 3-O-rutinoside prevents radiation induced oxidative damage and inflammation by coordinated regulation of Nrf2/ NF-κB/ NLRP3- inflammasome signaling in gastrointestine
- 27 November 2022
- Published by Elsevier in Phytomedicine Plus
- Vol. 3 (1)
Open AccessQuercetin 3-O-rutinoside prevents radiation induced oxidative damage and inflammation by coordinated regulation of Nrf2/ NF-κB/ NLRP3- inflammasome signaling in gastrointestine
- Open Access
- 21 January 2022
- Published by Defence Scientific Information and Documentation Centre in Defence Life Science Journal
- Vol. 7 (1) , 3-10
Investigation on Oral Toxicity of Diallyl Sulfide A Principle Organosulfur Compound Derived from Allium Sativum Garlic in Mice
Allium sativum (garlic) is used as food additives and medicines. Its health benefits are well known, which are mainly contributed by the active organosulfur compounds present in it. Though garlic widely used, but limited is known about preclinical acute toxicity of its organosulfur compounds in mice. The present study aimed at toxicity evaluation of diallyl sulfide (DAS) in C57BL/6 mice following oral administration at range of concentrations (40 mg/kg, 400 mg/kg, 800 mg/kg and 1600 mg/kg). Survival, hematological, organ coefficients, and histopathology studies were performed to establish the DAS toxicity in mice. Stability studies performed in vitro by HPLC showed rapid and time dependent changes in DAS area. A single oral dose upto 1600 mg/kg was well tolerated in mice without any significant changes in standard toxicological parameters. No death was recorded at the tested concentrations. Also no significant changes in the organ coefficient were observed when compared to vehicle treated and sham control. Mild alterations in liver pathology and hematological changes were observed post 1600 mg/kg DAS administration orally. This study demonstrates that single oral administration (upto 1600 mg/kg) of DAS is within the safe limits with no observable adverse effects in mice. Based on the safety profile of DAS, we conclude that DAS can be further explored for use in humans as a potential radiomitigator.
- 21 January 2022
- Published by Defence Scientific Information and Documentation Centre in Defence Life Science Journal
- Vol. 7 (1) , 3-10
Open AccessInvestigation on Oral Toxicity of Diallyl Sulfide A Principle Organosulfur Compound Derived from Allium Sativum Garlic in Mice
Allium sativum (garlic) is used as food additives and medicines. Its health benefits are well known, which are mainly contributed by the active organosulfur compounds present in it. Though garlic widely used, but limited is known about preclinical acute toxicity of its organosulfur compounds in mice. The present study aimed at toxicity evaluation of diallyl sulfide (DAS) in C57BL/6 mice following oral administration at range of concentrations (40 mg/kg, 400 mg/kg, 800 mg/kg and 1600 mg/kg). Survival, hematological, organ coefficients, and histopathology studies were performed to establish the DAS toxicity in mice. Stability studies performed in vitro by HPLC showed rapid and time dependent changes in DAS area. A single oral dose upto 1600 mg/kg was well tolerated in mice without any significant changes in standard toxicological parameters. No death was recorded at the tested concentrations. Also no significant changes in the organ coefficient were observed when compared to vehicle treated and sham control. Mild alterations in liver pathology and hematological changes were observed post 1600 mg/kg DAS administration orally. This study demonstrates that single oral administration (upto 1600 mg/kg) of DAS is within the safe limits with no observable adverse effects in mice. Based on the safety profile of DAS, we conclude that DAS can be further explored for use in humans as a potential radiomitigator.
- Open Access
- 3 June 2021
- Published by Defence Scientific Information and Documentation Centre in Defence Life Science Journal
- Vol. 6 (2) , 128-137
Quercetin 3 Rutinoside Facilitates Protection Against Radiation Induced Genotoxic and Oxidative Damage A Study in C57bl 6 Mice
Radiation-induced oxidative stress and haematopoietic genomic instability is the major concern during planned or unplanned exposure. Use of the natural phytochemicals is an emerging strategy to prevent from the harmful effects of radiation. In the current investigation, Quercetin 3-Rutinoside (Q-3-R), a polyphenolic bioflavonoid, has been evaluated against gamma radiation (2Gy) induced genotoxic damage and oxidative imbalance in mice. Mice were administered with Q-3-R (10mg/kg body weight) 1hr prior to irradiation and evaluated for its antioxidant potential. Anti-genotoxic potential was assessed in terms of chromosomal aberrations in bone marrow cells. Findings revealed that Q-3-R had very high reducing potential, effectively scavenged 1,1-Diphenyl-2-picryl hydrazyl (DPPH) and hydrogen peroxide radicals, chelated metal ions and inhibited lipid peroxidation in a dose dependant manner. The glutathione (GSH) levels were found elevated (p<0.05), while reduced malondialdehyde (MDA) levels were seen in blood and liver tissues of Q-3-R pretreated mice. Significant (p<0.01) reduction in Reactive Oxygen Species (ROS) levels and radiation induced aberrations (dicentrics, rings, fragments, end to end association, robertsonian translocation) following Q-3-R pretreatment was found in bone marrow cells. The present findings demonstrate that Q-3-R can effectively minimise radiation-induced genotoxic and oxidative damages and can be explored further to be used as a potent radioprotector in humans.
- 3 June 2021
- Published by Defence Scientific Information and Documentation Centre in Defence Life Science Journal
- Vol. 6 (2) , 128-137
Open AccessQuercetin 3 Rutinoside Facilitates Protection Against Radiation Induced Genotoxic and Oxidative Damage A Study in C57bl 6 Mice
Radiation-induced oxidative stress and haematopoietic genomic instability is the major concern during planned or unplanned exposure. Use of the natural phytochemicals is an emerging strategy to prevent from the harmful effects of radiation. In the current investigation, Quercetin 3-Rutinoside (Q-3-R), a polyphenolic bioflavonoid, has been evaluated against gamma radiation (2Gy) induced genotoxic damage and oxidative imbalance in mice. Mice were administered with Q-3-R (10mg/kg body weight) 1hr prior to irradiation and evaluated for its antioxidant potential. Anti-genotoxic potential was assessed in terms of chromosomal aberrations in bone marrow cells. Findings revealed that Q-3-R had very high reducing potential, effectively scavenged 1,1-Diphenyl-2-picryl hydrazyl (DPPH) and hydrogen peroxide radicals, chelated metal ions and inhibited lipid peroxidation in a dose dependant manner. The glutathione (GSH) levels were found elevated (p<0.05), while reduced malondialdehyde (MDA) levels were seen in blood and liver tissues of Q-3-R pretreated mice. Significant (p<0.01) reduction in Reactive Oxygen Species (ROS) levels and radiation induced aberrations (dicentrics, rings, fragments, end to end association, robertsonian translocation) following Q-3-R pretreatment was found in bone marrow cells. The present findings demonstrate that Q-3-R can effectively minimise radiation-induced genotoxic and oxidative damages and can be explored further to be used as a potent radioprotector in humans.